Lactobacillus Plantarum Polysaccharides for Metabolic Disease
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current probiotics can cause side effects such as infections and gene transfer to host microorganisms, and their stability and safety are concerns, particularly in vulnerable populations like children, while their effectiveness in preventing metabolic diseases like insulin resistance and obesity is limited.
Innovation Solution
Development of a pharmaceutical and food composition using Lactobacillus plantarum-derived polysaccharides or extracts, which are stable, safe, and effective in inhibiting inflammatory responses, adipogenesis, and improving metabolic health by interacting with TLR2 and the AMPK pathway.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If probiotics are administered to improve gut health and prevent metabolic diseases, then health benefits are achieved, but side effects such as infections, inflammatory responses, and gene transfer occur
Solution Approach 1:
The patent extracts and utilizes postbiotics (metabolites, functional proteins, cell lysates, short chain fatty acids, and exopolysaccharides) from Lactobacillus plantarum, separating the beneficial bioactive compounds from the living bacterial cells. This extraction eliminates the risks of infection and gene transfer associated with probiotics while preserving the health benefits through the use of these isolated postbiotic components.
Solution Approach 2:
The patent introduces postbiotics as an intermediary substance that mediates the health benefits between the bacterial source and the host. Instead of administering living bacteria directly, the metabolites and bioactive compounds serve as intermediaries that convey the beneficial effects without the risks associated with live microbial administration.
2Reliability
If Lactobacillus plantarum extract is used to inhibit inflammatory responses and adipogenesis, then anti-inflammatory and anti-obesity effects are achieved, but the complexity of identifying effective components increases
Solution Approach 1:
The patent identifies exopolysaccharides as a universal bioactive component from Lactobacillus plantarum that performs multiple functions: inhibiting inflammatory responses, preventing adipogenesis, and improving metabolic health. This multi-functionality simplifies the approach by focusing on a single predominant component rather than requiring identification and combination of multiple different active substances.
Solution Approach 2:
The patent utilizes ultrasound treatment as a physical parameter change to enhance the extraction and identification of bioactive components from Lactobacillus plantarum. The ultrasonic energy alters the physical state and accessibility of intracellular components, facilitating the isolation and characterization of exopolysaccharides and other bioactive substances.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Lactobacillus plantarum-derived polysaccharides or extracts demonstrate anti-inflammatory and anti-obesity effects by reducing inflammatory cytokines, inhibiting adipogenesis, and improving insulin resistance and liver fat, providing a stable and safe solution for metabolic disease prevention and treatment.
Implementation Method 1
The Lactobacillus plantarum-derived polysaccharide or the Lactobacillus plantarum extract of the present invention may exhibit anti-inflammatory efficacy by inhibiting an interaction between LPS and TLR4.
Implementation Method 2
The Lactobacillus plantarum-derived polysaccharide or the Lactobacillus plantarum extract of the present invention may interact with TLR2 to activate AMPK pathway, thereby preventing adipogenesis.
Data Source
AI summary
A method for preventing or treating a metabolic disease includes administering to an individual a composition comprising at least one of a Lactobacillus plantarum-derived polysaccharide or and a Lactobacillus plantarum extract. The metabolic disease may be metabolic disease is at least one selected from the group consisting of insulin resistance, type 2 diabetes, hyperlipidemia, fatty liver, obesity and/or inflammation.